Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Laboratorios Farmaceuticos Rovi SA

+ Add to Watchlist

41L:GR

13.775 EUR 0.115 0.84%

As of 09:57:31 ET on 02/27/2015.

Snapshot for Laboratorios Farmaceuticos Rovi SA (41L)

Open: 14.025 Day's Range: 13.690 - 14.025 Volume: 250
Previous Close: 13.660 52wk Range: 7.990 - 14.025 1-Yr Rtn: +42.70%

Stock Chart for 41L

No chart data available.
  • 41L:GR 14.025
  • 1D
  • 1M
  • 1Y
13.660
Interactive 41L Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 41L

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 25.4621
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2015) 0.5410
Est. PEG Ratio 1.5815
Market Cap (M EUR) 688.75
Shares Outstanding (M) 50.00
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.22%
Cash Dividend (EUR) 0.1352
Dividend Ex-Date
5 Year Dividend Growth 12.42%
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 41L

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for 41L

Laboratorios Farmaceuticos Rovi SA is a specialty pharmaceutical company. The Company researches, develops, manufactures, and markets small molecule and specialty biologic drugs. Rovi's services include contract manufacturing of aseptic filling and packaging of small-volume parenterals in prefilled syringes and vials and provides temperature-controlled storage facilities.

Juan Lopez-Belmonte LopezChairman/Co-CEOEnrique Castellon LealVice Chairman
Juan Lopez-Belmonte EncinaCo-CEO/General DirectorJavier Lopez-Belmonte EncinaChief Financial Officer
More Company Profile & Key Executives for 41L

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil